# An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

> **NCT04950712** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 537 (actual)

## Conditions studied

- Herpes Genitalis

## Interventions

- **PROCEDURE:** Blood sampling
- **PROCEDURE:** Anogenital lesion swab collection

## Key facts

- **NCT ID:** NCT04950712
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-09
- **Primary completion:** 2024-03-14
- **Final completion:** 2024-03-14
- **Target enrollment:** 537 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04950712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04950712, "An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04950712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*